Diamyd Medical

About:

Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development.

Website: http://www.diamyd.com/

Twitter/X: diamyd

Top Investors: JDRF (The Juvenile Diabetes Research Foundation), Pittsburgh Life Sciences Greenhouse, Anders Essen Möller, Bertil Lindkvist

Description:

Diamyd Medical develops the diabetes vaccine Diamyd®, an antigen-specific immunotherapy based on the exclusively licensed GAD-molecule. GABA constitutes alongside with the diabetes vaccine a key asset in Diamyd Medical and the Company uses its GABA in-licensed technology to develop a proprietary GABA drug product. Diamyd Medical’s shares are traded on Nasdaq Stockholm First North, ticker DMYD B.